TOMSK, RUSSIA / RankWire.AI / – Russian scientists have conducted initial assessments of a bioactive coating aimed at improving the interaction between titanium orthopedic implants and bone tissue. The innovative material incorporates calcium phosphate derived from hydroxyapatite and includes nitrogen compounds linked to nitric oxide production. Laboratory investigations revealed a marked increase in the survival rate of human mesenchymal stem cells on surfaces coated with this material compared to uncoated titanium. The team analyzed the coating’s structural features, chemical makeup, mechanical attributes, and biological effects. Their peer-reviewed results appeared in Applied Surface Science in 2026.
At Tomsk Polytechnic University, researchers developed the experimental coatings through reactive magnetron sputtering, utilizing a hydroxyapatite target within a vacuum chamber. During the process, they adjusted the nitrogen and argon gas ratios to observe how different mixes influenced the surface properties. Five different conditions were tested, from pure nitrogen to pure argon. The scientists then measured various parameters, including coating thickness, surface morphology, hardness, wettability, and chemical composition. Laboratory experiments also evaluated how living human cells responded to the modified titanium surfaces.
Results indicated that the amount of argon impacted several physical characteristics of the coatings. Surfaces deposited in pure argon proved denser and harder than those created in pure nitrogen. As the proportion of argon increased, coating thickness also grew. Chemical analysis revealed nitrogen-carbon and nitrogen-oxygen bonds present on the treated surfaces. The researchers then compared human mesenchymal stem cells grown on coated titanium with those exposed to uncoated titanium. The biological tests focused on cell viability and indicators associated with osteogenic differentiation.
Enhanced Cell Viability Observed in Coated Samples
According to the study, cell experiments demonstrated significantly improved survival rates on coated surfaces compared to uncoated titanium. After seven days, coatings with elevated nitrogen levels were also found to suppress activity in certain genes linked to early stages of bone-cell differentiation. Nevertheless, the cells maintained their ability to form bone tissue despite these genetic changes. All tests were conducted under controlled laboratory conditions using human mesenchymal stem cells. It is important to note that this research did not include clinical trials or evaluate the performance of the coatings in actual medical implant scenarios.
The biomedical evaluation was carried out by Immanuel Kant Baltic Federal University alongside Siberian State Medical University. The broader research team also included specialists from Saint Petersburg State University. This project was supported by Russia’s national science program. The scientists aimed to identify gas mixtures capable of producing coatings with advantageous physical, chemical, and biological properties. Since hydroxyapatite’s calcium phosphate structure closely resembles the mineral component in human bone, it is already used in implant coatings.
Research Still Limited to Laboratory Phase
The researchers plan to extend their testing beyond the initial seven-day cell study. Future work will involve examining stem cell behavior over 10 to 28 days, as well as investigating the dissolution rate of the coatings and measuring nitric oxide release in living tissue. These aspects were not covered in the published laboratory results. Currently, the focus remains on coated titanium substrates, their material properties, and responses of cells in vitro rather than clinical outcomes for orthopedic patients.
The study provides comprehensive laboratory data on how the ratio of nitrogen and argon influences calcium phosphate coatings on titanium surfaces. Variations in thickness, density, hardness, chemical bonding, and cellular response were documented across different gas mixtures. The research also confirmed that coated samples supported higher stem-cell survival than uncoated titanium under the experimental conditions. However, as a preclinical investigation, the findings do not confirm safety or efficacy in humans. Additional biological testing will be needed to evaluate properties not addressed in this initial work.